Inhibition of Hec1 as a novel approach for treatment of primary liver cancer.
about
Role of NEK2A in human cancer and its therapeutic potentials.Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation.Targeting NEK2 as a promising therapeutic approach for cancer treatment.TRIP13 is expressed in colorectal cancer and promotes cancer cell invasion.Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer.
P2860
Inhibition of Hec1 as a novel approach for treatment of primary liver cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Inhibition of Hec1 as a novel approach for treatment of primary liver cancer.
@en
type
label
Inhibition of Hec1 as a novel approach for treatment of primary liver cancer.
@en
prefLabel
Inhibition of Hec1 as a novel approach for treatment of primary liver cancer.
@en
P2093
P2860
P1476
Inhibition of Hec1 as a novel approach for treatment of primary liver cancer
@en
P2093
Chia-chi Chang
Chia-wei Liu
Gillian M G Lau
Her-Sheng Lin
Jia-Ming Chang
Jiann-Jyh Huang
Johnson Y N Lau
Kuo-Jang Kao
Lynn Y L Huang
Pei-Yi Tsai
P2860
P2888
P304
P356
10.1007/S00280-014-2540-7
P50
P577
2014-07-20T00:00:00Z
P5875
P6179
1045205573